ALKBH5 and rheumatoid arthritis: These results suggest that XFC exerts its therapeutic effects in RA by functionally modulating the ALKBH5–m6A–LINC00968 pathway, ultimately curbing neutrophil dysregulation and the resultant inflammatory damage.